
Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.

The dispute is already underway. In August, the Trump administration initiated a sweeping investigation into Chinese trade practices, including whether Chinese firms are investing in U.S. companies to steal their technology and whether they are forcing joint ventures, pressuring American companies that invest in China to transfer technology to a Chinese partner, or hacking U.S. companies’ software.

The Centers for Medicare and Medicaid Services has announced a new initiative designed to provide patients access to their electronic health records and share their data with their preferred health care providers.

New compounds targeting epigenetics have shown remarkable early activity in patients with lymphoma, according to data presented at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France. ESMO’s phase-I oncology meeting featured early clinical studies with BET inhibitors and EZH2 inhibitors.

Life science industry impacts N.J. economy in big way, C&W report says By Emily Bader New Jersey | Mar 7, 2018 at 11:44 am
The life science industry is fueling New Jersey’s economy through revenue and job growth, according to a report by Cushman & Wakefield.

Will Your Company be the Buzz of BIO?
Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships within the industry? Nominate your company to be the Buzz of BIO!
Winners receive complimentary registration that includes BIO One-on-One Partnering™, a Company Presentation slot in the BIO Business Forum, and marketing promotion to thousands of industry leaders.
Nominations End March 16

Summer R.I.S.E. (Real Interesting Summer Experience) is a unique opportunity for Montgomery County youth to explore potential careers and for our local businesses to participate in developing a talent pipeline. The initiative is led by WorkSource Montgomery, Inc. (WSM), Montgomery County Public Schools (MCPS) and supported by county and state government partners, local businesses and non-profit organizations. Local businesses and governmental organizations volunteer to bring rising high school juniors and seniors into their workplaces to provide hands‐on, real world career experiences.

Officials from Amazon.com toured sites in Washington, Montgomery County, Md., and Northern Virginia last week — the latest sign that the tech giant is seriously considering adding a second headquarters with as many as 50,000 jobs to the D.C. area, according to officials in all three jurisdictions.

PointClickCare Technologies, the leading cloud-based software vendor for the long-term and post-acute care (LTPAC) market, announced today its strategic partnership with Redox Inc., the leading integration platform for healthcare data exchange. Together, PointClickCare and Redox will work to bridge the gap between the acute and post-acute markets, empowering health systems with the visibility required for a truly coordinated and collaborative approach to care delivery across the healthcare continuum.

After a year of surging growth, Supernus Pharmaceuticals Inc. is building out a new home double its current size.